A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

BACKGROUND: Sorafenib monotherapy in patients with metastatic melanoma was explored in this multi-institutional phase II study. In correlative studies the impact of sorafenib on cyclin D1 and Ki67 was assessed. METHODOLOGY/PRINCIPAL FINDINGS: Thirty-six patients treatment-naïve advanced melanoma pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ott, Patrick A., Hamilton, Anne, Min, Christina, Safarzadeh-Amiri, Sara, Goldberg, Lauren, Yoon, Joanne, Yee, Herman, Buckley, Michael, Christos, Paul J., Wright, John J., Polsky, David, Osman, Iman, Liebes, Leonard, Pavlick, Anna C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012061/
https://www.ncbi.nlm.nih.gov/pubmed/21206909
http://dx.doi.org/10.1371/journal.pone.0015588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012061/
https://www.ncbi.nlm.nih.gov/pubmed/21206909
http://dx.doi.org/10.1371/journal.pone.0015588

Ejemplares similares